Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuning the Crystallite Size, Shape, and Magnetic Properties of Fe<sub>3</sub>O<sub>4</sub> Nanoparticles Using Annealing.

Materials (Basel, Switzerland)·2026
Same author

Emergence of magnetic monopole-like behavior in iron oxide nanoparticles grafted with chiral brushes: a chiral induced spin selectivity manifestation.

Materials horizons·2026
Same author

Interplay Between Exfoliation and Functionalization Strategies for Group VI Layered Transition Metal Dichalcogenide Dispersions.

Nanomaterials (Basel, Switzerland)·2026
Same author

Siloxane-Terminated Self-Assembled Monolayers for Mimicking Nanoscale Hydrophobic Polydimethylsiloxane Surfaces.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Stabilizing the Localized Surface Plasmon Resonance (LSPR) of Citrate-Synthesized Metal Nanoparticles in Organic Solvents.

Materials (Basel, Switzerland)·2025
Same author

Recent Advances in Polymer-Coated Metal and Metal Oxide Nanoparticles: From Design to Promising Applications.

Nanomaterials (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jul 19, 2025

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.6K

Nanoparticle-Based Strategies to Combat COVID-19.

Riddhiman Medhi1, Pannaree Srinoi1, Nhat Ngo1

  • 1Department of Chemistry and the Texas Center for Superconductivity, University of Houston, 4800 Calhoun Road, Houston, Texas 77204-5003, United States.

ACS Applied Nano Materials
|August 9, 2023
PubMed
Summary

Nanoparticles show promise for combating COVID-19 by aiding in diagnostics, therapeutics, and vaccine development. This review explores nanoparticle strategies against SARS-CoV-2 and other coronaviruses.

More Related Videos

Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device
06:02

Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device

Published on: March 22, 2022

9.2K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.6K

Related Experiment Videos

Last Updated: Jul 19, 2025

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.6K
Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device
06:02

Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device

Published on: March 22, 2022

9.2K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.6K

Area of Science:

  • Nanomedicine and Virology

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents a global health crisis with challenges in testing, therapeutics, and vaccines.
  • The virus's transmission by asymptomatic carriers strains testing resources, and effective treatments are lacking.

Purpose of the Study:

  • To review the potential of nanoparticle (NP)-based strategies for addressing COVID-19.
  • To explore NP applications in diagnostics, therapeutics, and vaccine development against SARS-CoV-2 and other coronaviruses.

Main Methods:

  • Review of existing literature on nanoparticle applications in virology, particularly against coronaviruses like SARS and MERS.
  • Analysis of NP characteristics and their potential interactions with SARS-CoV-2.
  • Synthesis of findings from previous antiviral NP studies and recent SARS-CoV-2 research.

Main Results:

  • Nanoparticles, due to their size and properties, can mimic viruses and interact with viral proteins, showing potential in diagnostics and treatment.
  • Previous studies demonstrate NP effectiveness against various viruses, including those in the Coronaviridae family.
  • Nanomaterial-based approaches offer promising avenues for developing diagnostics, therapeutics, and vaccines for COVID-19 and future pandemics.

Conclusions:

  • Nanoparticle-based strategies hold significant potential for combating COVID-19 and similar viral pandemics.
  • Further research into NP applications is crucial for expanding testing, developing effective treatments, and creating lasting immunity through vaccination.